CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $706,534 | +43.7% | 26,069 | +18.1% | 0.00% | 0.0% |
| Q2 2023 | $491,562 | -97.7% | 22,076 | -97.7% | 0.00% | -96.2% |
| Q1 2023 | $21,269,814 | +2062.5% | 981,078 | +1917.2% | 0.03% | +2500.0% |
| Q4 2022 | $983,587 | +12.8% | 48,635 | +45.3% | 0.00% | 0.0% |
| Q3 2022 | $872,000 | +100.9% | 33,482 | +84.7% | 0.00% | 0.0% |
| Q2 2022 | $434,000 | -10.3% | 18,127 | -15.6% | 0.00% | 0.0% |
| Q1 2022 | $484,000 | -2.8% | 21,485 | -14.2% | 0.00% | – |
| Q4 2021 | $498,000 | +57.6% | 25,040 | +56.5% | 0.00% | – |
| Q3 2021 | $316,000 | -37.2% | 15,998 | -29.7% | 0.00% | -100.0% |
| Q2 2021 | $503,000 | +33.8% | 22,741 | +45.1% | 0.00% | – |
| Q1 2021 | $376,000 | +0.8% | 15,676 | +9.9% | 0.00% | – |
| Q4 2020 | $373,000 | +41.8% | 14,264 | -23.5% | 0.00% | – |
| Q3 2019 | $263,000 | +182.8% | 18,634 | +44.8% | 0.00% | – |
| Q4 2016 | $93,000 | – | 12,868 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |